Gokbulut, P.
Kuskonmaz, S. M.
Koc, G.
Onder, C. E.
Yumusak, N.
Erel, O.
Nural, A. S.
Culha, C.
Article History
Received: 21 June 2022
Accepted: 30 November 2022
First Online: 10 December 2022
Declarations
:
: The authors declare there are no conflicts of interest.
: The study was conducted according to the ethical standards specified in the 1964 Declaration of Helsinki. Research and publication ethical rules were followed in our study. Our study was approved by the ethics committee of Ankara Training and Research Hospital Animal Experiments Local Ethics Committee, dated 26.07.2021, with a 0066 meeting and 668 decision number.
: In our animal study titled ‘Evaluation of the effects of empagliflozin on acute lung injury in rat intestinal ischemia– reperfusion model’, no informed consent is required.